• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

约旦儿童对新冠病毒的抗刺突蛋白和抗核衣壳IgG反应

Anti_spike and anti_nucleocapsid IgG responses to SARS-CoV-2 in children of Jordan.

作者信息

Qaqish Arwa, Abbas Manal Mohammad, Alkhateeb Mohammad, Al-Tamimi Mohammad, Mustafa Minas, Al-Shudifat Abdel-Ellah, Tarawneh Shahd, Dawoud Rand, Mryyian Amel, Al-Ajaleen Mu'ath

机构信息

Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan.

Department of Cellular Therapy and Applied Genomics, King Hussein Cancer Center (KHCC), Amman, Jordan.

出版信息

Heliyon. 2024 May 4;10(9):e30631. doi: 10.1016/j.heliyon.2024.e30631. eCollection 2024 May 15.

DOI:10.1016/j.heliyon.2024.e30631
PMID:38765100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11101777/
Abstract

BACKGROUND

It is proven that children have significantly milder COVID-19 disease compared to adults. Various immunological characteristics influence this age-related difference in protection against COVID-19. Pediatric COVID-19 in Jordan is extremely under reported.

OBJECTIVES

The primary goal of this work is to identify the anti_S and anti_N antibody responses in a random group of children in Jordan and compare it to that of naturally infected-unvaccinated adults.

METHODS

151 unvaccinated children, 4 days to 18 years old, were screened for anti_S and anti_N antibodies. History of COVID-19 infection or exposure to infection and symptom severity were reported by parents on a special questionnaire.

RESULTS

78.9 % and 65.3 % of participants were seropositive for anti_S IgG and anti_N Abs, respectively. There was a remarkable association between age and anti_S IgG and anti_N IgG antibody titers, as children aged 12 years or older had increased anti_S IgG titers (mean = 19.3 BAU/mL) compared to younger groups (means of 10.15, 9.24, 7.91 BAU/mL for age groups 6-12, 1-6, less than 1 year, respectively). Gender did not show a statistically important role in anti_S and anti_N IgG seropositivity rates or titers. Children displayed significantly elevated anti_S titers (mean = 13.23 BAU/mL) compared to naturally infected adults (mean = 9.72 BAU/mL), in contrast, adults' anti_N titers (mean = 39.64 U/mL) were significantly higher compared to those of children (mean = 10.77 U/mL).

CONCLUSIONS

The current work provides evidence of distinctly robust and persistent humoral immunity displayed by high anti_S and anti_N IgG in children, even >12 months post-infection. Age was the only factor that had a significant statistical impact on anti_S and anti_N Ab levels among the pediatric group in this study. Children exhibited significantly higher anti_S titers than naturally infected adults. In contrast, adults' anti_N titers were significantly higher. Such information can assist direct pediatric SARS-CoV-2 immunization programs, with implications for creating age-targeted strategies for diagnostic and population protection measures.

摘要

背景

事实证明,与成年人相比,儿童感染新冠病毒后的症状要轻得多。多种免疫特征影响了这种与年龄相关的对新冠病毒的防护差异。约旦儿童新冠病毒感染情况的报告极少。

目的

这项研究的主要目的是确定约旦一组随机选取的儿童中抗S和抗N抗体的反应,并将其与自然感染但未接种疫苗的成年人进行比较。

方法

对151名年龄在4天至18岁之间未接种疫苗的儿童进行抗S和抗N抗体筛查。家长通过一份特殊问卷报告儿童的新冠病毒感染史或接触感染情况以及症状严重程度。

结果

分别有78.9%和65.3%的参与者抗S IgG和抗N抗体血清呈阳性。年龄与抗S IgG和抗N IgG抗体滴度之间存在显著关联,12岁及以上儿童的抗S IgG滴度(平均=19.3 BAU/mL)高于较年轻组(6 - 12岁、1 - 6岁、小于1岁年龄组的平均值分别为10.15、9.24、7.91 BAU/mL)。性别在抗S和抗N IgG血清阳性率或滴度方面未显示出统计学上的重要作用。与自然感染的成年人(平均=9.72 BAU/mL)相比,儿童的抗S滴度显著升高(平均=13.23 BAU/mL),相反,成年人的抗N滴度(平均=39.64 U/mL)显著高于儿童(平均=10.77 U/mL)。

结论

目前的研究提供了证据,表明儿童即使在感染后超过12个月,抗S和抗N IgG也显示出明显强大且持久的体液免疫。在本研究中,年龄是对儿科组抗S和抗N抗体水平有显著统计学影响的唯一因素。儿童的抗S滴度显著高于自然感染的成年人。相比之下,成年人的抗N滴度显著更高。这些信息有助于指导儿科新冠病毒免疫计划,对制定针对不同年龄的诊断和人群保护措施策略具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e22d/11101777/ca61d65a29f8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e22d/11101777/3945c3095604/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e22d/11101777/0aae499bba17/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e22d/11101777/ca61d65a29f8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e22d/11101777/3945c3095604/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e22d/11101777/0aae499bba17/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e22d/11101777/ca61d65a29f8/gr3.jpg

相似文献

1
Anti_spike and anti_nucleocapsid IgG responses to SARS-CoV-2 in children of Jordan.约旦儿童对新冠病毒的抗刺突蛋白和抗核衣壳IgG反应
Heliyon. 2024 May 4;10(9):e30631. doi: 10.1016/j.heliyon.2024.e30631. eCollection 2024 May 15.
2
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
3
Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients.评估血液中针对同源 Gam-COVID-Vac(卫星 V)或异源卫星 V/mRNA-1273(Moderna)疫苗对 SARS-CoV-2 的体液免疫反应在透析患者中的作用。
J Nephrol. 2023 Apr;36(3):861-872. doi: 10.1007/s40620-022-01446-2. Epub 2022 Sep 24.
4
Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.影响医护人员抗 SARS-CoV-2 刺突 IgG 抗体效价的因素:一项横断面研究。
J Med Virol. 2023 Jan;95(1):e28300. doi: 10.1002/jmv.28300. Epub 2022 Nov 18.
5
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.儿童感染前奥密克戎变异株后对关注的 SARS-CoV-2 变异株的抗体反应:一项观察性队列研究。
EBioMedicine. 2022 Sep;83:104230. doi: 10.1016/j.ebiom.2022.104230. Epub 2022 Aug 18.
6
Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?mRNA SARS-CoV-2 疫苗接种后抗刺突抗体的持久性在既往感染者中更长:是否可以延迟加强针接种?
Infection. 2022 Dec;50(6):1573-1577. doi: 10.1007/s15010-022-01816-9. Epub 2022 Apr 7.
7
Seroprevalence of SARS-CoV-2 antibodies in children with nephrotic syndrome and chronic kidney disease: a cross-sectional study from India.肾病综合征和慢性肾脏病患儿中SARS-CoV-2抗体的血清流行率:一项来自印度的横断面研究。
Pediatr Nephrol. 2025 Feb;40(2):441-447. doi: 10.1007/s00467-024-06534-y. Epub 2024 Sep 27.
8
Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals.在未感染和既往感染个体中,接受 BNT162b2 疫苗第一、第二和第三剂后,针对 SARS-CoV-2 的特异性抗体反应的差异:一项在医护人员中进行的为期 1 年的观察性研究。
Front Immunol. 2022 May 27;13:876533. doi: 10.3389/fimmu.2022.876533. eCollection 2022.
9
SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals.与未接种个体相比,mRNA疫苗和灭活病毒疫苗的SARS-CoV-2核衣壳抗体反应
Vaccines (Basel). 2022 Apr 20;10(5):643. doi: 10.3390/vaccines10050643.
10
Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade.在接受白细胞介素 6 阻断治疗后从重症 COVID-19 中康复的患者中对 SARS-CoV-2 具有强大的长期免疫力。
EBioMedicine. 2022 Aug;82:104153. doi: 10.1016/j.ebiom.2022.104153. Epub 2022 Jul 8.

本文引用的文献

1
Anti-S and Anti-N Antibody Responses of COVID-19 Vaccine Recipients.新冠疫苗接种者的抗S和抗N抗体反应
Vaccines (Basel). 2023 Aug 22;11(9):1398. doi: 10.3390/vaccines11091398.
2
Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies.儿童和青少年的长期新冠:患病率、临床表现及管理策略
Clin Exp Pediatr. 2023 Nov;66(11):465-474. doi: 10.3345/cep.2023.00472. Epub 2023 Jun 19.
3
Understanding COVID-19 in children: immune determinants and post-infection conditions.了解儿童 COVID-19:免疫决定因素和感染后状况。
Pediatr Res. 2023 Aug;94(2):434-442. doi: 10.1038/s41390-023-02549-7. Epub 2023 Mar 6.
4
Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals.新型冠状病毒肺炎患者、新型冠状病毒疫苗接种者和随机个体的免疫球蛋白反应。
PLoS One. 2023 Feb 14;18(2):e0281689. doi: 10.1371/journal.pone.0281689. eCollection 2023.
5
Humoral immunity for durable control of SARS-CoV-2 and its variants.用于持久控制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其变体的体液免疫。
Inflamm Regen. 2023 Jan 12;43(1):4. doi: 10.1186/s41232-023-00255-9.
6
SARS-CoV-2 infected children form early immune memory responses dominated by nucleocapsid-specific CD8+ T cells and antibodies.SARS-CoV-2 感染的儿童形成早期免疫记忆反应,主要由核衣壳特异性 CD8+ T 细胞和抗体主导。
Front Immunol. 2022 Nov 2;13:1033364. doi: 10.3389/fimmu.2022.1033364. eCollection 2022.
7
Manifestations of COVID-19 infection in children with malignancy: A single-center experience in Jordan.恶性肿瘤患儿新冠病毒感染的表现:约旦的单中心经验
World J Virol. 2022 Sep 25;11(5):321-330. doi: 10.5501/wjv.v11.i5.321.
8
Two years of COVID-19 pandemic in Jordan: A focus on epidemiology and vaccination.约旦的两年新冠疫情:聚焦流行病学与疫苗接种
J Glob Health. 2022 Oct 1;12:03063. doi: 10.7189/jogh.12.03063.
9
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.儿童感染前奥密克戎变异株后对关注的 SARS-CoV-2 变异株的抗体反应:一项观察性队列研究。
EBioMedicine. 2022 Sep;83:104230. doi: 10.1016/j.ebiom.2022.104230. Epub 2022 Aug 18.
10
SARS-CoV-2 infection in children and implications for vaccination.儿童感染 SARS-CoV-2 及其对疫苗接种的影响。
Pediatr Res. 2023 Apr;93(5):1177-1187. doi: 10.1038/s41390-022-02254-x. Epub 2022 Aug 15.